Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Gustavo Drügg, Hahn"'
Autor:
Panu Wetwittayakhlang, Christine Verdon, Michael Starr, Gustavo Drügg Hahn, Petra A. Golovics, Talat Bessissow, Waqqas Afif, Gary Wild, Alain Bitton, Peter L. Lakatos
Publikováno v:
The Turkish Journal of Gastroenterology, Vol 34, Iss 6, Pp 603-610 (2023)
Externí odkaz:
https://doaj.org/article/7b44bebf7a8041698455c9eeeac1543d
Publikováno v:
Case Reports in Gastroenterology, Vol 16, Iss 1, Pp 116-121 (2022)
Crohn’s disease (CD) and Lynch syndrome (LS) are two different entities, yet both are associated with increased risk of colorectal cancer (CRC). We present the case of a young female patient in long-standing remission of her ileocolonic luminal CD,
Externí odkaz:
https://doaj.org/article/b833245b87a347f293adcbcbfabdc3be
Autor:
Panu Wetwittayakhlang, Farah Albader, Petra A Golovics, Gustavo Drügg Hahn, Talat Bessissow, Alain Bitton, Waqqas Afif, Gary Wild, Peter L Lakatos
Publikováno v:
Canadian Journal of Gastroenterology and Hepatology, Vol 2021 (2021)
Background and Aims. The impact of COVID-19 has been of great concern in patients with inflammatory bowel disease (IBD) worldwide, including an increased risk of severe outcomes and/or possible flare of IBD. This study aims to evaluate prevalence, ou
Externí odkaz:
https://doaj.org/article/d88f9b2cd7d2454b99ee6cfcf7de5bb8
Autor:
Gustavo Drügg Hahn, Petra Anna Golovics, Panu Wetwittayakhlang, Alex Al Khoury, Talat Bessissow, Peter Laszlo Lakatos
Publikováno v:
Biomedicines, Vol 10, Iss 4, p 749 (2022)
Inflammatory bowel disease (IBD) is a chronic, life-long inflammatory condition of the gastrointestinal tract. Treatment strategy depends on the severity of the disease course. IBD physicians need to be aware of the life-long treatment options availa
Externí odkaz:
https://doaj.org/article/9d66a165fa8144519ad1f7fe47a08ad6
Autor:
Peter Laszlo Lakatos, Alain Bitton, Gary Wild, Waqqas Afif, Talat Bessissow, Marc Bradette, Jonathan Wyse, Albert Cohen, Gustavo Drügg Hahn, Elie Ganni, Alex Al Khoury, Petra A Golovics, Panu Wetwittayakhlang
Publikováno v:
Journal of Gastrointestinal and Liver Diseases. 31:403-410
Background and Aims: Objective monitoring and effective early treatment using a treat-to-target approach are key to improving therapeutic outcomes in IBD patients. This study aimed to assess adherence to objective monitoring (clinical, biomarkers, an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ee9750e872d082251913b2df6b6243d0
https://doi.org/10.15403/jgld-4375
https://doi.org/10.15403/jgld-4375
Autor:
Gustavo Drügg, Hahn, Jean-Frédéric, LeBlanc, Petra Anna, Golovics, Panu, Wetwittayakhlang, Abdulrahman, Qatomah, Anna, Wang, Levon, Boodaghians, Jeremy, Liu Chen Kiow, Maryam, Al Ali, Gary, Wild, Waqqas, Afif, Alain, Bitton, Peter Laszlo, Lakatos, Talat, Bessissow
Publikováno v:
World Journal of Gastroenterology. 28:4823-4833
Biologic therapy resulted in a significant positive impact on the management of inflammatory bowel disease (IBD) however data on the efficacy and side effects of these therapies in the elderly is scant.To evaluate retrospectively the drug sustainabil
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d4132a3b0ecac53db924725a87a6bf56
https://doi.org/10.3748/wjg.v28.i33.4823
https://doi.org/10.3748/wjg.v28.i33.4823
Autor:
Gustavo Drügg Hahn, Petra Anna Golovics, Panu Wetwittayakhlang, Dirlene Melo Santa Maria, Usiara Britto, Gary Edward Wild, Waqqas Afif, Alain Bitton, Talat Bessissow, Peter Laszlo Lakatos
Publikováno v:
Journal of clinical medicine. 11(15)
Background and Aim: Newer biologics appeared safer in landmark clinical trials, but their safety is understudied in vulnerable populations. The aim of the present study was to perform a systematic review and meta-analysis to assess the safety of avai
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3730f8fed00cd44c72f6c45e794ace6d
https://pubmed.ncbi.nlm.nih.gov/35956040
https://pubmed.ncbi.nlm.nih.gov/35956040
Autor:
Petra Anna Golovics, Christine Verdon, Panu Wetwittayakhlang, Christopher Filliter, Lorant Gonczi, Gustavo Drügg Hahn, Gary E. Wild, Waqqas Afif, Alain Bitton, Talat Bessissow, Paul Brassard, Peter L. Lakatos
Publikováno v:
Journal of Clinical Medicine, Vol 11, Iss 686, p 686 (2022)
Journal of Clinical Medicine; Volume 11; Issue 3; Pages: 686
Journal of Clinical Medicine; Volume 11; Issue 3; Pages: 686
Background: Chronic inflammatory diseases are linked to an increased risk of atherothrombotic events, but the risk associated with inflammatory bowel disease (IBD) is controversial. We therefore examined the risk of and risk factors for myocardial in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d25a44c0c2d3a5a8cb939ca3f070fc4f
https://www.mdpi.com/2077-0383/11/3/686
https://www.mdpi.com/2077-0383/11/3/686
Autor:
Farah Albader, Gustavo Drügg Hahn, Gary Wild, Petra Anna Golovics, Alain Bitton, Panu Wetwittayakhlang, Peter L. Lakatos, Talat Bessissow, Waqqas Afif
Publikováno v:
Canadian Journal of Gastroenterology & Hepatology
Canadian Journal of Gastroenterology and Hepatology, Vol 2021 (2021)
Canadian Journal of Gastroenterology and Hepatology, Vol 2021 (2021)
Background and Aims. The impact of COVID-19 has been of great concern in patients with inflammatory bowel disease (IBD) worldwide, including an increased risk of severe outcomes and/or possible flare of IBD. This study aims to evaluate prevalence, ou
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c1a4532779837ec5080448c78611043c
https://pubmed.ncbi.nlm.nih.gov/34858891
https://pubmed.ncbi.nlm.nih.gov/34858891
Publikováno v:
Journal of Clinical Medicine. 11:3045
Fistulizing Crohn’s disease (FCD) remains the most challenging aspect of treating patients with CD. FCD can occur in up to 30% of patients with CD and may lead to significant disability and impaired quality of life. The optimal treatment strategies
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ec4fbbd53ffcdc05e5b10344d7100e3b
https://doi.org/10.3390/jcm11113045
https://doi.org/10.3390/jcm11113045